Patient | Arrhythmia | Antiarrhythmic drugs | CV | Pace | Continuous atrial pacing | Catheter ablation |
---|---|---|---|---|---|---|
1 | VT/VF | A,L,P,Mg | + | − | − | − |
2 | IMVT | A,P,Mg,L,F,Br,B | − | + | + | + |
3 | IMVT | A,L,Mg | + | + | + | − |
4 | VT/VF | A,L,Br | + | + | + | − |
5 | VT | A | + | + | + | − |
6 | IMVT | A,B,M,Mg | + | + | − | − |
7 | VT | A,L,Mg | + | − | − | − |
8 | VT/VF | A | + | − | − | − |
9 | VT/VF | A | + | − | − | − |
10 | IMVT | A,L,Mg | + | + | + | − |
11 | IMVT | A,D,L,Mg,E | − | + | − | − |
12 | IMVT | A,L,Mg | − | + | + | − |
13 | IMVT | A,L,Mg,E,P | + | + | + | − |
14 | VT | A,F,L,Mg | + | − | − | − |
15 | IMVT | A,L,Mg | + | + | − | − |
16 | VT/VF | A | + | − | − | − |
17 | IMVT | A,P | + | + | − | − |
18 | VT/VF | A,P,F | + | + | − | − |
19 | VT/VF | A,V,L,B | + | + | − | − |
20 | VT | A,Mg | + | − | − | − |
21 | IMVT | A,L,Mg | + | + | + | − |
A, amiodarone; B, β blocker; Br, bretylium; CV, dc cardioversion; D, disopyramide; E, esmolol; F, flecainide; IMVT, incessant monomorphic ventricular tachycardia; L, lignocaine (lidocaine); M, mexilitine; Mg, magnesium; P, procainamide; Pace, termination by pacing; V, verapamil, VF, ventricular fibrillation; VT, ventricular tachycardia.